|
Market Closed -
Nasdaq
16:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 6.960 USD | -4.53% |
|
-27.88% | -42.67% |
| 09-15 | Ocular Therapeutix, Inc. Completes Pre-NDA Meeting With FDA For AXPAXLI In Wet AMD | CI |
| 09-15 | Ocular Therapeutix Plans to File Eye Disease Drug Marketing Application in Q4 | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -4.53% | -27.88% | -34.59% | -27.80% | -42.67% | -39.00% | +152.17% | -28.91% | 0.00% | 1.53B | |
| -0.61% | -3.43% | -0.57% | -5.85% | +6.34% | +36.07% | +115.04% | +408.27% | +1,309.01% | 1,019B | |
| -1.02% | -5.60% | -6.98% | -2.66% | +23.72% | +35.72% | +64.63% | +60.80% | +115.48% | 617B | |
| +1.11% | -0.58% | +2.48% | +0.67% | +15.02% | +12.36% | +77.95% | +141.72% | +317.17% | 464B | |
| +0.34% | -3.01% | -4.01% | +11.38% | +37.09% | +61.79% | +41.24% | +73.65% | +131.03% | 356B | |
| +0.65% | -2.36% | -1.87% | +4.58% | +5.73% | +20.32% | +40.66% | +0.16% | +44.16% | 333B | |
| +1.04% | -3.28% | -6.41% | -6.14% | +7.14% | +10.98% | +34.61% | +54.50% | +52.10% | 267B | |
| +0.29% | -4.82% | -1.26% | -15.67% | -13.78% | -6.57% | +9.06% | +34.26% | +135.82% | 244B | |
| -1.04% | -2.79% | -7.82% | +7.72% | +23.14% | +35.30% | +51.84% | +90.62% | +140.55% | 218B | |
| -1.87% | -4.10% | -4.14% | +10.26% | +17.92% | +28.44% | +93.66% | +114.24% | +87.39% | 179B | |
| -0.94% | -2.89% | -18.06% | -23.72% | -24.69% | -36.63% | -61.47% | -21.80% | +76.41% | 166B | |
| -1.14% | -3.03% | -2.28% | +14.31% | +11.65% | +1.57% | -16.54% | -34.46% | -17.56% | 158B | |
| -0.40% | -4.08% | -7.58% | -4.41% | +11.33% | +25.15% | +43.00% | +184.52% | +484.04% | 128B | |
| -0.50% | -2.72% | -8.49% | +5.20% | +13.37% | +34.54% | +7.79% | +3.77% | +10.76% | 125B | |
| +0.38% | +4.11% | -0.63% | +14.75% | +10.00% | +22.25% | +104.12% | +351.23% | +444.66% | 105B | |
| +0.80% | -0.71% | -5.55% | -4.05% | -13.58% | -16.66% | -30.50% | -14.34% | +4.00% | 95.48B | |
| -0.39% | -4.76% | -3.59% | -10.67% | -2.90% | +9.62% | +19.45% | +2.10% | -16.09% | 94.34B | |
| +0.57% | -4.46% | +30.55% | +138.23% | +544.32% | +566.94% | +82.25% | -41.69% | - | 75.86B | |
| +0.05% | -6.71% | -11.18% | +12.37% | -4.75% | +22.53% | -9.79% | +32.37% | +85.10% | 73.41B | |
| -0.93% | -2.06% | +0.37% | -5.04% | +10.60% | +12.81% | -12.26% | -27.25% | +41.18% | 66.99B | |
| Average | -0.37% | -4.11% | -4.58% | +5.67% | +31.75% | +41.88% | +40.34% | +69.19% | +181.33% | 239.35B | |
| Weighted average by Cap. | -0.19% | -3.25% | -3.15% | +1.24% | +19.20% | +32.64% | +56.30% | +137.19% | +389.39% |
- Stock Market
- Stocks
- OCUL Stock
- Sector Ocular Therapeutix, Inc.
Select your edition
All financial news and data tailored to specific country editions
